Focus:
Cardiovascular
-
7 July 2020 News
FDA clears Abbott’s Gallant devices for cardiac arrhythmia
Abbott has received the US Food and Drug Administration (FDA) approval for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices.
-
20 May 2020 News
FDA grants breakthrough status to Thermedical for SERF ablation system
The US Food and Drug Administration (FDA) has awarded Breakthrough Device Designation to Thermedical for Saline Enhanced Radiofrequency (SERF) ablation system and Durablate catheter.
-
12 March 2020 Sponsored
“The sky’s the limit”: Q&A with Sandvik’s Gary Davies
Medical Device Network spoke with Sandvik’s medical business unit manager, Gary Davies, about the company’s natural evolution into precision medical wires and what the future holds for the industry.
-
25 February 2020 News
Wearable AI sensor predicts worsening heart failure
A new artificial intelligence (AI) powered wearable sensor could help doctors remotely detect critical changes in heart failure patients days before any health crisis occurs.
-
21 February 2020 News
Cardiovalve’s Transcatheter Tricuspid Valve System gets FDA approval
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Israel-based medical device company Cardiovalve’s Transcatheter Tricuspid Valve Replacement System for tricuspid regurgitation (TR) indication.
-
20 February 2020 News
US researchers develop heart valve designed to grow with children
A new type of heart valve could remove the need for children with congenital heart disease to undergo multiple open-heart surgeries by growing alongside them.
-
19 February 2020 News
Endotronix enrols two patients for PROACTIVE-HF pivotal trial
US-based digital health and medical technology company Endotronix has enrolled first two patients in the PROACTIVE-HF pivotal trial, a pre-market investigational device-exempt (IDE) study evaluating the safety and efficacy of...
-
19 February 2020 News
Abbot receives CE mark for heart rhythm management devices
US-based health care and medical device company Abbott has secured CE Mark for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices in Europe.
-
14 February 2020 Comment
FDA approves Eko cardiology technology advances
Earlier this month, Eko, an artificial intelligence (AI) digital health company, was granted FDA approval for its latest cardio-technology. The US-based company has developed new algorithms for its novel AI...
-
10 February 2020 News
Caption Health’s cardiac ultrasound software gets marketing approval
Caption Health has secured authorisation from the US Food and Drug Administration (FDA) to market its cardiac ultrasound software.